Last week, Healio reported live from the Endocrine Society’s annual meeting, the first one to be held in person in 3 years.
During one presentation, researchers reported that excessive use of a mobile device was associated with a higher BMI, sleep issues and depression. Data showed that each hour per day increase in screen time was associated with a 0.05 kg/m2 to 0.07 kg/m2 increase in BMI. It was the top story in endocrinology last week.
Another top story was about a presentation on the association between obesity and reproductive health. Researchers found that women with obesity had fewer ovarian follicles grow to 10 mm and fewer anovulatory follicles achieve dominance compared with women with normal weight.
Read these and more top stories in endocrinology below:
Excessive mobile device use linked to higher BMI, other adverse health outcomes
People who spend more time per day using wireless mobile devices are more likely to have a higher BMI, lower-quality sleep and other adverse health outcomes, according to a presenter at ENDO 2022. Read more.
Obesity suppresses ovarian follicle development in women with regular menstrual cycles
Women with obesity have fewer ovarian follicles that remained static for longer and regressed more slowly compared with those found in women with normal weight, according to recent findings. Read more.
Empagliflozin lowers risk for kidney stones in type 2 diabetes
Use of Jardiance (empagliflozin, Boehringer Ingelheim/Eli Lilly) was associated with a nearly 40% reduced risk for nephrolithiasis among people with type 2 diabetes, according to recent study findings. Read more.
NSAIDs reduce efficacy of clodronate in preventing bone loss, fractures
In a cohort of women, NSAID use significantly decreased the efficacy of the bisphosphonate clodronate for preventing bone loss and fractures, according to findings from a post hoc analysis. Read more.
Pandemic-related stress linked to increase in ovulatory disturbances among women
Stress related to the COVID-19 pandemic was associated with an increase in subclinical ovulatory disturbances among women without a change in menstrual cycle length, data show. Read more.